Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques
article
OA: closed
CC0
⤵ 16 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- Development of the selective progesterone receptor modulator CDB-2914 for clinical indications via openalex
- Effect of long-term treatment with low-dose mifepristone on the endometrium via openalex
- Effects of the Progesterone Receptor Modulator VA2914 in a Continuous Low Dose on the Hypothalamic-Pituitary-Ovarian Axis and Endometrium in Normal Women: A Prospective, Randomized, Placebo-Controlled Trial via openalex
- Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study via openalex
- Role of nonhuman primate models in the discovery and clinical development of selective progesterone receptor modulators (SPRMs) via openalex
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis via openalex
- The Mirena(R) levonorgestrel system via openalex
- W2016699471 via openalex
- W2026392453 via openalex
- W2045180596 via openalex
- W2047203443 via openalex
- W2051109327 via openalex
- W2087289721 via openalex
- W2090345475 via openalex
- W2091507123 via openalex
- W2095904930 via openalex
- W2097240287 via openalex
- W2122896665 via openalex
- W2156181845 via openalex
- W2411716433 via openalex
- W4235271779 via openalex
- W4235506169 via openalex
- W4248847810 via openalex
- W378857221 via openalex
- W4285719527 via openalex
- W1586557470 via openalex
- W1976187655 via openalex
- W1982488750 via openalex
- W1984592479 via openalex
- W2001262571 via openalex
- W2007951223 via openalex
Cited by (16)
- Medical treatments of endometriosis: a review 2022
- The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles 2021
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? 2018
- Medical Management of Endometriosis 2017
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
- Summary of Future Developments 2017
- Investigational Medical Therapies for Endometriosis: Current Data and Future Trends 2017
- Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies 2016
- Experimental Treatments of Endometriosis 2015
- Translational In Vivo Models for Women’s Health: The Nonhuman Primate Endometrium—A Predictive Model for Assessing Steroid Receptor Modulators 2015
- An update on the pharmacological management of endometriosis 2013
- Intérêt actuel des selective progesterone receptor modulators (SPRM) dans l’endométriose 2013
- The immninent dawn of SPRMs in obstetrics and gynecology 2012
- Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
- Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety 2011
- The Translational Efficacy of a Nonsteroidal Progesterone Receptor Antagonist, 4-[3-Cyclopropyl-1-(mesylmethyl)-5-methyl-1H-pyrazol-4-yl]oxy,-2,6-dimethylbenzonitrile (PF-02413873), on Endometrial Growth in Macaque and Human 2011
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK